Tag Archives: Orsini Specialty

Biopharma, Limited Distribution Drugs, Rare/Orphan Disease, Specialty Pharmacy

Specialty Pharmacy News Roundup: December 2023

Posted on by John Santilli

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

Continue reading →
Specialty Drug, Specialty Pharmacy

Specialty Pharmacy News Roundup: June 2023

Posted on by John Santilli

The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry

Continue reading →
Specialty Drug, Specialty HUBs, Specialty Pharmacy

PantherRx Rare and Orsini Specialty Pharmacy Chosen as Partners for OXLUMO

Posted on by John Santilli
08
Dec

Alnylam® Pharmaceuticals selected PantherRx Rare and Orsini Specialty Pharmacy as limited distribution partners for OXLUMO™ (lumasiran). OXLUMO is the first and only treatment approved for primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients. PH1 is an ultra-rare genetic disease characterized by the overproduction of oxalate, a waste product that […]

Continue reading →